Evidence map›Paper›PMID 30552177›Full record

ArticleAnnals of the rheumatic diseases2019

NFIL3 mutations alter immune homeostasis and sensitise for arthritis pathology.

Susan Schlenner, Emanuela Pasciuto, Vasiliki Lagou, Oliver Burton, Teresa Prezzemolo, Steffie Junius, Carlos P Roca, Cyril Seillet, Cynthia Louis, James Dooley and 7 more

Open access · hybridAbstract readTwin Study
In one paragraph

Article in Annals of the rheumatic diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. A new border for circadian rhythm gene NFIL3 in diverse fields of cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Susan SchlennerDepartment of Microbiology and Immunology, KUL - University of Leuven, Leuven, Belgium.
Emanuela PasciutoDepartment of Microbiology and Immunology, KUL - University of Leuven, Leuven, Belgium.
Vasiliki LagouDepartment of Microbiology and Immunology, KUL - University of Leuven, Leuven, Belgium.
Oliver BurtonDepartment of Microbiology and Immunology, KUL - University of Leuven, Leuven, Belgium.
Teresa PrezzemoloDepartment of Microbiology and Immunology, KUL - University of Leuven, Leuven, Belgium.
Steffie JuniusDepartment of Microbiology and Immunology, KUL - University of Leuven, Leuven, Belgium.
Carlos P RocaDepartment of Microbiology and Immunology, KUL - University of Leuven, Leuven, Belgium.
Cyril SeilletWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Cynthia LouisWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
James DooleyDepartment of Microbiology and Immunology, KUL - University of Leuven, Leuven, Belgium.
Kylie LuongWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Erika Van NieuwenhoveDepartment of Microbiology and Immunology, KUL - University of Leuven, Leuven, Belgium.ORCID 0000-0002-7933-1800
Ian P WicksWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Gabrielle BelzWalter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Stéphanie Humblet-BaronDepartment of Microbiology and Immunology, KUL - University of Leuven, Leuven, Belgium adrian.liston@vib.be carine.wouters@uzleuven.be stephanie.humbletbaron@vib-kuleuven.be.
Carine WoutersDepartment of Microbiology and Immunology, KUL - University of Leuven, Leuven, Belgium adrian.liston@vib.be carine.wouters@uzleuven.be stephanie.humbletbaron@vib-kuleuven.be.
Adrian ListonDepartment of Microbiology and Immunology, KUL - University of Leuven, Leuven, Belgium adrian.liston@vib.be carine.wouters@uzleuven.be stephanie.humbletbaron@vib-kuleuven.be.
VIB-KU Leuven Center for Brain & Disease Research · BEThe University of Melbourne · AUVIB-KU Leuven Center for Microbiology · BEWalter and Eliza Hall Institute of Medical Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectives

methodsHere, we characterised a kindred of two monozygotic twin girls with juvenile idiopathic arthritis at the genetic and immunological level, using whole exome sequencing, single cell sequencing and flow cytometry. Parallel studies were performed in a mouse model.

resultsThe patients inherited a novel p.M170I in NFIL3 from each of the parents. The mutant form of NFIL3 demonstrated reduced stability in vitro. The potential contribution of this mutation to arthritis susceptibility was demonstrated through a preclinical model, where Nfil3-deficient mice upregulated IL-1β production, with more severe arthritis symptoms on disease induction. Single cell sequencing of patient blood quantified the transcriptional dysfunctions present across the peripheral immune system, converging on IL-1β as a pivotal cytokine.

conclusionsNFIL3 mutation can sensitise for arthritis development, in mice and humans, and rewires the innate immune system for IL-1β over-production.

Indexed as

AnimalsArthritis, JuvenileBasic-Leucine Zipper Transcription FactorsChildDisease Models, AnimalExome SequencingFemaleHumansImmunity, InnateInterleukin-1betaMiceMutationTwins, MonozygoticBasic-Leucine Zipper Transcription FactorsInterleukin-1betaNFIL3 protein, humangeneticIL-1βjuvenile idiopathic arthritismacrophagesNFIL3

Identifiers

PMID30552177
PMCPMC6390028
OpenAlexW2904369547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.